83 related articles for article (PubMed ID: 8167001)
1. Serine-stretch protein (SERP) of Plasmodium falciparum corresponds to the exoantigen Ag2, a target of antibodies associated with protection against malaria.
Jakobsen PH; Hundt E; Hansen MB; Knapp B
APMIS; 1994 Jan; 102(1):53-8. PubMed ID: 8167001
[TBL] [Abstract][Full Text] [Related]
2. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.
Enders B; Hundt E; Knapp B
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():413-22. PubMed ID: 1343721
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
4. Tumour necrosis factor and interleukin-6 production induced by components associated with merozoite proteins of Plasmodium falciparum.
Jakobsen PH; Moon R; Ridley RG; Bate CA; Taverne J; Hansen MB; Takacs B; Playfair JH; McBride JS
Parasite Immunol; 1993 Apr; 15(4):229-37. PubMed ID: 8506119
[TBL] [Abstract][Full Text] [Related]
5. Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230.
Healer J; McGuinness D; Carter R; Riley E
Parasitology; 1999 Nov; 119 ( Pt 5)():425-33. PubMed ID: 10599074
[TBL] [Abstract][Full Text] [Related]
6. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
[TBL] [Abstract][Full Text] [Related]
7. Acquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection Against Plasmodium falciparum Malaria in Children.
Irani V; Ramsland PA; Guy AJ; Siba PM; Mueller I; Richards JS; Beeson JG
Clin Infect Dis; 2015 Oct; 61(8):1244-52. PubMed ID: 26136391
[TBL] [Abstract][Full Text] [Related]
8. Rice-produced MSP142 of Plasmodium falciparum elicits antibodies that inhibit parasite growth in vitro.
Chen Q; Liang W; Qian F; Qian B; Cao J; Zhang D; Xu Y; Tang L
Parasite Immunol; 2016 Oct; 38(10):635-41. PubMed ID: 27493141
[TBL] [Abstract][Full Text] [Related]
9. Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
Costa FT; Fusaï T; Parzy D; Sterkers Y; Torrentino M; Douki JB; Traoré B; Petres S; Scherf A; Gysin J
J Infect Dis; 2003 Jul; 188(1):153-64. PubMed ID: 12825185
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine.
Longley RJ; Halbroth BR; Salman AM; Ewer KJ; Hodgson SH; Janse CJ; Khan SM; Hill AVS; Spencer AJ
Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28031267
[TBL] [Abstract][Full Text] [Related]
11. A recombinant hybrid protein as antigen for an anti-blood stage malaria vaccine: a study on the conservation of a protective component.
Knapp B; Nau U; Scherf A
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():179-84. PubMed ID: 1343688
[TBL] [Abstract][Full Text] [Related]
12. Passive immunoprotection of Plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigen.
Dreyer AM; Matile H; Papastogiannidis P; Kamber J; Favuzza P; Voss TS; Wittlin S; Pluschke G
J Immunol; 2012 Jun; 188(12):6225-37. PubMed ID: 22593616
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
Rouhani M; Zakeri S; Mehrizi AA; Djadid ND
Malar J; 2015 Feb; 14():58. PubMed ID: 25652589
[TBL] [Abstract][Full Text] [Related]
14. Malaria vaccines based on the Plasmodium falciparum merozoite surface protein 3--should we avoid amino acid sequence polymorphisms or embrace them?
Saul A
J Infect Dis; 2007 Jan; 195(2):171-3. PubMed ID: 17191161
[No Abstract] [Full Text] [Related]
15. Transmission-blocking immunity against malaria and other vector-borne diseases.
Kaslow DC
Curr Opin Immunol; 1993 Aug; 5(4):557-65. PubMed ID: 8216932
[TBL] [Abstract][Full Text] [Related]
16. Generation of cross-protective antibodies against Plasmodium falciparum sequestration by immunization with an erythrocyte membrane protein 1-duffy binding-like 1 alpha domain.
Moll K; Pettersson F; Vogt AM; Jonsson C; Rasti N; Ahuja S; Spångberg M; Mercereau-Puijalon O; Arnot DE; Wahlgren M; Chen Q
Infect Immun; 2007 Jan; 75(1):211-9. PubMed ID: 17074852
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and antigenic properties of Pf332-C231, a fragment of a non-repeat region of the Plasmodium falciparum antigen Pf332.
Balogun HA; Vasconcelos NM; Lindberg R; Haeggström M; Moll K; Chen Q; Wahlgren M; Berzins K
Vaccine; 2009 Dec; 28(1):90-7. PubMed ID: 19822232
[TBL] [Abstract][Full Text] [Related]
18. Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions.
Gangnard S; Lewit-Bentley A; Dechavanne S; Srivastava A; Amirat F; Bentley GA; Gamain B
Sci Rep; 2015 Oct; 5():14868. PubMed ID: 26450557
[TBL] [Abstract][Full Text] [Related]
19. Construction of a synthetic immunogen: use of the natural immunomodulator polytuftsin in malaria vaccines against RESA antigen of Plasmodium falciparum.
Pawan K; Ivanov BB; Kabilan L; Rao DN
Vaccine; 1994 Jul; 12(9):819-24. PubMed ID: 7526572
[TBL] [Abstract][Full Text] [Related]
20. Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies.
Pandey KC; Singh S; Pattnaik P; Pillai CR; Pillai U; Lynn A; Jain SK; Chitnis CE
Mol Biochem Parasitol; 2002 Aug; 123(1):23-33. PubMed ID: 12165386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
